Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

434 public trials 103 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

Cemiplimab and ISA101b Vaccine in Adult Participants With Recurrent/Metastatic Human Papillomavirus (HPV)16 Cervical Cancer Who Have Experienced Disease Progression After First Line Chemotherapy

NCT04646005

Conditions
Adenocarcinoma, Carcinoma, Cervical Cancer, +21 more
Locations
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • Regeneron Research Site Orange, California, United States
  • Universitair Ziekenhuis Gent Ghent, East Flanders, Belgium
View all 26 locations
View Trial Details
Completed

Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma

NCT05678218

Conditions
Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +15 more
Locations
  • University Hospital of Ghent Ghent, Belgium
  • Maastricht UMC+ Maastricht, Limburg, Netherlands
  • Amsterdam University Medical Center Amsterdam, North Holland, Netherlands
  • University Medical Center Groningen Groningen, Provincie Groningen, Netherlands
View Trial Details
Completed

Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer

NCT03963739

Conditions
Adenocarcinoma, Carcinoma, Genital Diseases, +15 more
Locations
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Mercy Hospital Fort Smith Fort Smith, Arkansas, United States
  • CHI Saint Vincent Cancer Center Hot Springs Hot Springs, Arkansas, United States
  • Kaiser Permanente-Anaheim Anaheim, California, United States
View all 326 locations
View Trial Details
Completed

Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study

NCT04400474

Conditions
Adenocarcinoma, Anaplastic Thyroid Cancer, Carcinoma, +11 more
Locations
  • Hospital Germans Trias i Pujol - ICO Badalona Badalona, Barcelona, Spain
  • Hospital Duran i Reynals - ICO L'Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital General Universitario Elche Alicante, Spain
  • Hospital Universitari Vall d'Hebron Barcelona, Spain
View all 15 locations
View Trial Details
Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03037385

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UC Irvine Medical Center Orange, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 71 locations
View Trial Details

Related conditions